Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line

Cancer Chemotherapy and Pharmacology

Volumn 51, Issue 4, 2003, Pages 271-283

  Yamasaki, Fumiyuki ^a   Hama, Seiji ^a   Yoshioka, Hiroyuki ^b   Kajiwara, Yoshinori ^a   Yahara, Kaita ^a   Sugiyama, Kazuhiko ^a   Heike, Yuji ^c   Arita, Kazunori ^a   Kurisu, Kaoru ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

Apoptosis; p16; p21; Staurosporine

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; PROTEIN KINASE; PROTEIN P16; PROTEIN P21; RETINOBLASTOMA PROTEIN; STAUROSPORINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION;

EID: 0038239643     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-002-0562-z     Document Type: Article

References (52)

1. Abe K, Yoshida M, Usui T, Horinouchi S, Beppu T (1991) Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases. Exp Cell Res 192:122
2. Baltuch GH, Couldwell WT, Villemure JG, Yong VW (1993) Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 33:495
3. Baltuch GH, Dooley NP, Couldwell WT, Yong VW (1993) Staurosporine differentially inhibits glioma versus non-glioma cell lines. J Neurooncol 16:141
4. Belizario JE, Dinarello CA (1991) Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle. Cancer Res 51:2379
5. Bossy-Wetzel E, Newmeyer DD, Green DR (1998) Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17:37
6. Bredel M, Pollack IF (1997) The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy. Acta Neurochir (Wien) 139:1000
7. Bredel M, Pollack IF, Freund JM, Rusnak J, Lazo JS (1999) Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion. J Neurooncol 41:9
8. Bruno S, Ardelt B, Skierski JS, Traganos F, Darzynkiewicz Z (1992) Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Cancer Res 52:470
9. Chen X, Lowe M, Herliczek T, Hall MJ, Danes C, Lawrence DA, Keyomarsi K (2000) Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G1 arrest. J Natl Cancer Inst 92:1999
10. Chin LS, Murray SF, Doherty PF, Singh SK (1999) K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c. Cancer Invest 17:391
11. Couldwell WT, Hinton DR, Law RE (1994) Protein kinase C and growth regulation in malignant gliomas. Neurosurgery 35:1184
12. Crissman HA, Gadbois DM, Tobey RA, Bradbury EM (1991) Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. Proc Natl Acad Sci U S A 88:7580
13. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114
14. Donna A, Betta PG, Ribotta M, Maran E, Mazzucco G, Mollo F, Bellingeri D, Libener R (1992) Mitogenic effects of a mesothelial cell growth factor: evidence for a potential autocrine regulation of normal and malignant mesothelial cell proliferation. Int J Exp Pathol 73:193
15. Egan SE, Weinberg RA (1993) The pathway to signal achievement. Nature 365:781
16. Fallon RJ (1990) Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes. Biochem Biophys Res Commun 170:1191
17. Feng M, Cabrera G, Deshane J, Scanlon KJ, Curiel DT (1995) Neoplastic reversion accomplished by high-efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res 55:2024
18. Fueyo J, Gomez-Manzano C, Yung WK, Clayman GL, Liu TJ, Bruner J, Levin VA, Kyritsis AP (1996) Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 12:103
19. Fujita-Yamaguchi Y, Kathuria S (1988) Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor. Biochem Biophys Res Commun 157:955
20. Gadbois DM, Hamaguchi JR, Swank RA, Bradbury EM (1992) Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases. Biochem Biophys Res Commun 184:80
21. Gescher A (1998) Analogs of staurosporine: potential anticancer drugs? Gen Pharmacol 31:721
22. Giangaspero F, Burger PC (1983) Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases. Cancer 52:2320
23. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WK (1996) Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56:694
24. Hama S, Sadatomo T, Yoshioka H, Kurisu K, Tahara E, Naruse I, Heike Y, Saijo N (1997) Transformation of human glioma cell lines with the p16 gene inhibits cell proliferation. Anticancer Res 17:1933
25. Hama S, Heike Y, Naruse I, Takahashi M, Yoshioka H, Arita K, Kurisu K, Goldman CK, Curiel DT, Saijo N (1998) Adenovirus-mediated p16 gene transfer prevents drug-induced cell death through G1 arrest in human glioma cells. Int J Cancer 77:47
26. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS 3rd, James CD (1994) CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 54:5804
27. Heald R, McLoughlin M, McKeon F (1993) Human weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 74:463
28. Kawabe S, Roth JA, Wilson DR, Meyn RE (2000) Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner. Oncogene 19:5359
29. Kawada M, Uehara Y, Mizuno S, Yamori T, Tsuruo T (1998) Up-regulation of p27Kip1 correlates inversely with anchorage-independent growth of human cancer cell lines. Jpn J Cancer Res 89:110
30. Kleihues P, Ohgaki H (1997) Genetics of glioma progression and the definition of primary and secondary glioblastoma. Brain Pathol 7:1131
31. Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS, Raben D, Curiel DT (1998) Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 58:5738
32. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I (1996) Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A 93:1320
33. Niggli V, Keller H (1991) On the role of protein kinases in regulating neutrophil actin association with the cytoskeleton. J Biol Chem 266:7927
34. Nishi K, Schnier JB, Bradbury EM (1998) The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest. Exp Cell Res 243:222
35. Nishizuka Y (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607
36. Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193
37. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753
38. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90
39. Norbury C, MacFarlane M, Fearnhead H, Cohen GM (1994) Cdc2 activation is not required for thymocyte apoptosis. Biochem Biophys Res Commun 202:1400
40. Orr MS, Reinhold W, Yu L, Schreiber-Agus N, O'Connor PM (1998) An important role for the retinoblastoma protein in staurosporine-induced G1 arrest in murine embryonic fibroblasts. J Biol Chem 273:3803
41. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr (1990) Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways. J Neurosurg 73:98
42. Qiao L, Koutsos M, Tsai LL, Kozoni V, Guzman J, Shift SJ, Rigas B (1996) Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon adenocarcinoma cells. Cancer Lett 107:83
43. SUC1-coated microtitration plates. Anticancer Res 11:1581
44. Schnier JB, Nishi K, Goodrich DW, Bradbury EM (1996) G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637. Proc Natl Acad Sci U S A 93:5941
45. Sedlak J, Hunakova L, Sulikova M, Chorvath B (1997) Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multi-drug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells. Leuk Res 21:449
46. Shan B, Lee WH (1994) Deregulated expression of E2F1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14:8166
47. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH (1994) Premature p34cdc2 activation required for apoptosis. Science 263:1143
48. Tam SW, Schlegel R (1992) Staurosporine overrides checkpoints for mitotic onset in BHK cells. Cell Growth Differ 3:811
49. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F (1986) Staurosporine, a potent inhibitor of phospholipid/Ca+ + dependent protein kinase. Biochem Biophys Res Commun 135:397
50. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323
51. Wu X, Levine AJ (1994) p53 and E2F1 cooperate to mediate apoptosis. Proc Natl Acad Sci U S A 91:3602
52. Yokozaki H (2000) Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int 50:767